Trials / Completed
CompletedNCT06000332
Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Inogen Inc. · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to describe the effect of the Inogen Rove 6 Portable Oxygen Concentrator on peripheral oxygen saturation in adults receiving supplemental oxygen at night and examine whether the device can adequately maintain oxygen saturation during sleep.
Detailed description
The study design is a prospective, single site, single arm, open label, pilot study. The aim of this study is to describe the effect of the Inogen Rove 6 Portable Oxygen Concentrator on peripheral oxygen saturation in adults receiving supplemental oxygen at night and examine whether the device can adequately maintain oxygen saturation during sleep, i.e., achieve target with initial titration setting and/or with any needed adjustments of setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | InogenOne Rove 6 Portable Oxygen Concentrator | overnight use of Portable Oxygen Concentrator, 6 hours minimum |
Timeline
- Start date
- 2023-10-17
- Primary completion
- 2023-12-21
- Completion
- 2023-12-21
- First posted
- 2023-08-21
- Last updated
- 2024-01-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06000332. Inclusion in this directory is not an endorsement.